SCP Vitalife Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Regentis BiomaterialsJun 2026
Developing innovative biodegradable hydrogels for local repair of damaged cartilage and bone with unique in-vivo biodegradation profiles.
BiotechHerzliya
Galit Reske(Executive Officer)Arie Gordashnikov(Executive Officer)Susan Alpert(Director)Pini Ben-Elazar(Director)Keith Valentine(Director)Efraim Cohen-Arazi(Director)
Board seatJeff Dykan· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.